Establishment of a successful assessment and treatment service for Australian prison inmates with chronic hepatitis C.

作者: Boonwaat Leng , Paul Haber , Michael Levy , Andrew Lloyd , None

DOI: 10.5694/J.1326-5377.2010.TB03605.X

关键词: Case-control studyCohort studyHepatitis CHepatitisPsychiatryMethadonePediatricsRetrospective cohort studyPrisonObservational studyMedicine

摘要: Objective To evaluate the assessment and treatment outcomes of a prison hepatitis service. Design setting A retrospective, observational cohort study inmates who attended clinics from 1996 to 2005 at correctional centres in New South Wales. Patients Inmates clinics, including nested case-control series patients received antiviral age- sex-matched did not receive treatment. Main outcome measures Demographic clinical characteristics service; correlates selection for treatment; virological Results Of 1043 851 were men (82%) 994 (95%) referred HCV infection; mean age this group was 33 years (range, 18-74 years). In (185 treated 186 untreated patients), biased by culturally linguistically diverse background, current methadone or psychiatric status. group, 76 138 genotyped had genotype that is predictive favourable response, small minority those with available liver biopsy results established cirrhosis (7/119 patients). whom complete follow-up data available, 55% achieved sustained response 100% adhered therapy. addition, episodes especially complicated. Conclusion Although population has high rates injecting drug use poor mental health, imprisonment offers an opportunity chronic infection.

参考文章(17)
RICHARD HALLINAN, ANDREW BYRNE, JANAKI AMIN, GREGORY J DORE, Hepatitis C virus prevalence and outcomes among injecting drug users on opioid replacement therapy. Journal of Gastroenterology and Hepatology. ,vol. 20, pp. 1082- 1086 ,(2005) , 10.1111/J.1440-1746.2005.03882.X
R. G. Batey, T. Jones, C. McAllister, Prisons and HCV: a review and a report on an experience in New South Wales Australia. International Journal of Prisoner Health. ,vol. 4, pp. 156- 163 ,(2008) , 10.1080/17449200802264712
Jay H. Hoofnagle, Leonard B. Seeff, Peginterferon and Ribavirin for Chronic Hepatitis C The New England Journal of Medicine. ,vol. 355, pp. 2444- 2451 ,(2006) , 10.1056/NEJMCT061675
Anne C. Spaulding, Cindy M. Weinbaum, Daryl T.-Y. Lau, Richard Sterling, Leonard B. Seeff, Harold S. Margolis, Jay H. Hoofnagle, A Framework for Management of Hepatitis C in Prisons Annals of Internal Medicine. ,vol. 144, pp. 762- 769 ,(2006) , 10.7326/0003-4819-144-10-200605160-00010
Karina Razali, Hla Hla Thein, Jane Bell, Mark Cooper-Stanbury, Kate Dolan, Greg Dore, Jacob George, John Kaldor, Maria Karvelas, Jiong Li, Lisa Maher, Sharyn McGregor, Margaret Hellard, Fiona Poeder, Julianne Quaine, Kim Stewart, Helen Tyrrell, Martin Weltman, Owen Westcott, Alex Wodak, Matthew Law, Modelling the hepatitis C virus epidemic in Australia. Drug and Alcohol Dependence. ,vol. 91, pp. 228- 235 ,(2007) , 10.1016/J.DRUGALCDEP.2007.05.026
Scott A. Allen, Anne C. Spaulding, Albert M. Osei, Lynn E. Taylor, Asya M. Cabral, Josiah D. Rich, Treatment of Chronic Hepatitis C in a State Correctional Facility Annals of Internal Medicine. ,vol. 138, pp. 187- 190 ,(2003) , 10.7326/0003-4819-138-3-200302040-00010
Anthony J Freeman, Gregory J Dore, Matthew G Law, Max Thorpe, Jan Von Overbeck, Andrew R Lloyd, George Marinos, John M Kaldor, Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology. ,vol. 34, pp. 809- 816 ,(2001) , 10.1053/JHEP.2001.27831
Diana Sylvestre, Hepatitis C treatment in drug users: perception versus evidence. European Journal of Gastroenterology & Hepatology. ,vol. 18, pp. 129- 130 ,(2006) , 10.1097/00042737-200602000-00003